8/F, 35 QRC Building, No.35 Queens Road, Central, Hong Kong
hkmagicure@gmail.com
  • Lorlatinib (Lorbrena)

    Lorbrena (lorlatinib) is indicated for the treatment of patients with anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung cancer (...

    Lung Cancer
  • Tepmetko (Tepotinib)

    Tepmetko is a kinase inhibitor indicated for the treatment of adult patients with metastatic non-small cell lung cancer (NSCLC) harboring mesenchymal-e...

    Lung Cancer
  • Portrazza (Necitumumab)

    Necitumumab is an anti-EGFR recombinant human monoclonal antibody of the IgG1 kappa isotype that specifically binds to the ligand binding site of the h...

    Lung Cancer
  • Rybrevant (Amivantamab-vmjw)

    Rybrevant (Amivantamab-vmjw)...

    Lung Cancer
  • Cyramza (Ramucirumab)

    ---Indications and Usage--- Cyramza is a human vascular endothelial growth factor receptor 2 (VEGFR2) antagonist indicated: (1) as a single agent or in...

    Lung CancerGastric CancerLiver CancerColorectal Cancer
  • Cabometyx (Cabozantinib)

    Cabozantinib, developed by Exelixis Biopharmaceuticals, USA, is a broad-spectrum anticancer drug with multiple targets, including MET, VEGFR1/2/3, ROS1...

    Lung CancerLiver CancerKidney CancerThyroid Cancer
  • Retevmo (Selpercatinib)

    Retevmo is a kinase inhibitor indicated for the treatment of: 1) Adult patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) ...

    Lung CancerThyroid Cancer
  • Lumakras (Sotorasib)

    Lumakras (sotorasib)...

    Lung Cancer
  • Entrectinib (Rozlytrek)

    Adult patients with ROS1-positive metastatic non-small cell lung cancer (NSCLC) as detected by an FDA-approved test. Adult and pediatric patients 12 ye...

    Lung Cancer
  • Tabrecta (Capmatinib)

    Capmatinib is a kinase inhibitor.The chemical name is 2-Fluoro-N-methyl-4-[7-(quinolin-6-ylmethyl)imidazo[1,2-b][1,2,4]triazin-2-yl]benzamidehydrogen c...

    Lung Cancer
  • Of 1Page10Record